title: Pharmaceutical approval update.
abstract: Idelalisib (Zydelig) for certain types of leukemia and lymphoma, peginterferon beta-1a (Plegridy) for relapsing forms of multiple sclerosis, and suvorexant (Belsomra) for insomnia.
authors.forename: Kunj
authors.initials: K
authors.lastname: Gohil